ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.483,75
0,25%
S&P 500
5.180,15
-0,15%
Dow Jones
38.891,02
0,02%
Euro vs US Dollar
1,0753
0,03%
Bitcoin
62.357,75
0,04%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Arecor Therapeutics Plc (AREC)

  7. Arecor Therapeutics Plc (AREC) News

AREC

Arecor Therapeutics (AREC)

Arecor Therapeutics Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:AREC
DatumZeitQuelleÜberschriftSymbolFirma
03/05/202419h02Alliance NewsAlliance NewsIN BRIEF: Arecor Therapeutics delays publication of 2023 resultsLSE:ARECArecor Therapeutics Plc
03/05/202419h02Alliance NewsAlliance NewsIN BRIEF: Arecor Therapeutics delays publication of 2023 resultsLSE:ARECArecor Therapeutics Plc
03/05/202417h44RNS Regulatory NewsArecor Therapeutics PLC Publication of Full Year Financial Results delayedLSE:ARECArecor Therapeutics Plc
29/04/202408h00RNS Regulatory NewsArecor Therapeutics PLC Notice of resultsLSE:ARECArecor Therapeutics Plc
23/04/202412h02Alliance NewsAlliance NewsArecor chief financial officer to leave in July after five yearsLSE:ARECArecor Therapeutics Plc
23/04/202412h02Alliance NewsAlliance NewsArecor chief financial officer to leave in July after five yearsLSE:ARECArecor Therapeutics Plc
23/04/202408h00RNS Regulatory NewsArecor Therapeutics PLC BOARD CHANGELSE:ARECArecor Therapeutics Plc
12/03/202413h16Alliance NewsAlliance NewsArecor to develop "holy grail" diabetes treatment with partner TRxLSE:ARECArecor Therapeutics Plc
12/03/202413h16Alliance NewsAlliance NewsArecor to develop "holy grail" diabetes treatment with partner TRxLSE:ARECArecor Therapeutics Plc
12/03/202409h58RNS Regulatory NewsArecor Therapeutics PLC Arecor and TRx Biosciences research collaborationLSE:ARECArecor Therapeutics Plc
12/03/202408h00RNS Non-RegulatoryArecor Therapeutics PLC Arecor and TRx Biosciences research collaborationLSE:ARECArecor Therapeutics Plc
29/02/202420h42Alliance NewsAlliance NewsEARNINGS AND TRADING: East Star, Getech strike Kazakhstan JVLSE:ARECArecor Therapeutics Plc
29/02/202420h42Alliance NewsAlliance NewsEARNINGS AND TRADING: East Star, Getech strike Kazakhstan JVLSE:ARECArecor Therapeutics Plc
29/02/202408h00RNS Regulatory NewsArecor Therapeutics PLC Arecor announces launch of Ogluo® in NetherlandsLSE:ARECArecor Therapeutics Plc
01/02/202415h24Alliance NewsAlliance NewsArecor Therapeutics hails Arestat as 2023 performance "strong"LSE:ARECArecor Therapeutics Plc
01/02/202415h24Alliance NewsAlliance NewsArecor Therapeutics hails Arestat as 2023 performance "strong"LSE:ARECArecor Therapeutics Plc
01/02/202408h00RNS Regulatory NewsArecor Therapeutics PLC Year End Trading UpdateLSE:ARECArecor Therapeutics Plc
23/01/202422h47Alliance NewsAlliance NewsIN BRIEF: Arecor pleased as investee Inhibrx sells therapy to SanofiLSE:ARECArecor Therapeutics Plc
23/01/202422h47Alliance NewsAlliance NewsIN BRIEF: Arecor pleased as investee Inhibrx sells therapy to SanofiLSE:ARECArecor Therapeutics Plc
23/01/202417h58UK RegulatoryArecor Therapeutics PLC Arecor announces update on INBRX-101LSE:ARECArecor Therapeutics Plc
18/01/202419h26Alliance NewsAlliance NewsTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsLSE:ARECArecor Therapeutics Plc
18/01/202419h26Alliance NewsAlliance NewsTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsLSE:ARECArecor Therapeutics Plc
18/01/202408h00UK RegulatoryArecor Therapeutics PLC Arecor granted key European patentLSE:ARECArecor Therapeutics Plc
08/01/202412h34Alliance NewsAlliance NewsArecor expands speciality hospital collaboration with partnerLSE:ARECArecor Therapeutics Plc
08/01/202412h34Alliance NewsAlliance NewsArecor expands speciality hospital collaboration with partnerLSE:ARECArecor Therapeutics Plc
08/01/202408h00UK RegulatoryArecor Therapeutics PLC Expansion of specialty hospital collaborationLSE:ARECArecor Therapeutics Plc
03/01/202408h00UK RegulatoryArecor Therapeutics PLC Appointment of SVP for Tetris Pharma LtdLSE:ARECArecor Therapeutics Plc
04/12/202316h42Alliance NewsAlliance NewsArecor inks co-development deal with global medical companyLSE:ARECArecor Therapeutics Plc
04/12/202316h42Alliance NewsAlliance NewsArecor inks co-development deal with global medical companyLSE:ARECArecor Therapeutics Plc
04/12/202308h00UK RegulatoryArecor Therapeutics PLC Agreement with global medical products companyLSE:ARECArecor Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AREC

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
DBI
SDXP
SDAX
TG
D7G
Nel ASA
NYSE
MCD
McDonalds
TG
MBG
MercedesBenz
TG
TUI1
Tui
NYSE
KO
Coca Cola
TG
DTE
Deutsche Telekom
TG
ALV
Allianz
DBI
TDXP
Tec DAX
COIN
ETHUSD
Ethereum
TG
NOV
Novo Nordisk
TG
BAS
BASF
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten